THE TOLERABILITY OF ORAL EXELON ##MG/ DAY WAS SIMILAR TO THAT OF THE ##CM PATCH DELIVERING ##. ##MG/ ## HR, WITH DISCONTINUATION RATES DUE TO GASTROINTESTINAL (GI)-RELATED ADVERSE EVENTS, SUCH AS NAUSEA AND VOMITING, AT ##. ##% AND ##. ##%, RESPECTIVELY.
The poster presentations were entitled as " Masitinib in imatinib-naive advanced gastrointestinal stromal tumor (GIST): Five-year follow-up of the French Sarcoma Group Phase II trial"; " Masitinib in comparison to imatinib as first line therapy of patients with advanced
It provides products across various therapeutic areas including hematology, neuroscience, immunology, genetic disease, ophthalmic, gastrointestinal, endocrine, hereditary angioedema, cancer and other diseases.
Report covers products from therapy areas Central Nervous System, Oncology, Gastrointestinal, Immunology and Infectious Disease which include indications Alzheimer' s Disease, Liver Fibrosis, Autoimmune Disorders, Breast Cancer, Cancer Pain, Ebolavirus Infections (Ebola Hemorrhagic Feve
Hanmi Pharma' s products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others.
Aug 31, 2017: Probiodrug reports financial results for H1 2017 and corporate update
Skin and gastrointestinal organ system related adverse events were observed in a higher frequency in the PQ## arm compared to placebo and occurred in the majority in the first half of the treatment period.